Notice of Availability of Environmental Assessment and Finding of No Significant Impact for License Amendment to Byproduct Materials License No. 25-19852-01 for Unrestricted Release of Building 11 of the GlaxoSmithKline Biologicals-Hamilton Facility in Hamilton, MT, 39732-39734 [E8-15675]
Download as PDF
<![CDATA[
39732
Federal Register / Vol. 73, No. 133 / Thursday, July 10, 2008 / Notices
I. Introduction
The U.S. Nuclear Regulatory
Commission (NRC) is issuing for public
comment a draft regulatory guide in the
agency’s ‘‘Regulatory Guide’’ series.
This series was developed to describe
and make available to the public such
information as methods that are
acceptable to the NRC staff for
implementing specific parts of the
NRC’s regulations, techniques that the
staff uses in evaluating specific
problems or postulated accidents, and
data that the staff needs in its review of
applications for permits and licenses.
The draft regulatory guide (DG),
entitled ‘‘Physical Models for Design
and Operation of Hydraulic Structures
and Systems for Nuclear Power Plants,’’
is temporarily identified by its task
number, DG–1198, which should be
mentioned in all related
correspondence.
This guide describes the desired
coordination of an applicant with the
staff of the NRC and the detail and
documentation of data and studies that
an applicant should include in the
preliminary safety analysis report
(PSAR) or final safety analysis report
(FSAR) to support the use of physical
hydraulic model testing for predicting
the performance of hydraulic structures
and systems for nuclear power plants.
The regulatory position of this guide is
applicable only to physical models used
to predict the action or interaction of
surface waters with features located
outside of containment. The
recommendations of this guide do not
apply to internal plant systems or
structures.
Title 10, Section 50.34(a)(3)(ii) of the
Code of Federal Regulations (10 CFR
50.34(a)(3)(ii)) requires that the PSAR
include information on the design bases
of the facility and the relation of the
design bases to the principal design
criteria. In part, 10 CFR 50.34(a)(4)
requires a preliminary analysis of the
adequacy of structures, systems, and
components provided for the prevention
of accidents and the mitigation of the
consequences of accidents.
jlentini on PROD1PC65 with NOTICES
II. Further Information
The NRC staff is soliciting comments
on DG–1198. Comments may be
accompanied by relevant information or
supporting data, and should mention
DG–1198 in the subject line. Comments
submitted in writing or in electronic
form will be made available to the
public in their entirety through the
NRC’s Agencywide Documents Access
and Management System (ADAMS).
Personal information will not be
removed from the comments. Comments
VerDate Aug<31>2005
16:58 Jul 09, 2008
Jkt 214001
may be submitted by any of the
following methods:
1. Mail to: Rulemaking, Directives,
and Editing Branch, Office of
Administration, U.S. Nuclear Regulatory
Commission, Washington, DC 20555–
0001.
2. E-mail to: NRCREP@nrc.gov.
3. Hand-deliver to: Rulemaking,
Directives, and Editing Branch, Office of
Administration, U.S. Nuclear Regulatory
Commission, 11555 Rockville Pike,
Rockville, Maryland 20852, between
7:30 a.m. and 4:15 p.m. on Federal
workdays.
4. Fax to: Rulemaking, Directives, and
Editing Branch, Office of
Administration, U.S. Nuclear Regulatory
Commission at (301) 415–5144.
Requests for technical information
about DG–1198 may be directed to John
Burke at (301) 415–1529 or e-mail to
John.Burke@nrc.gov.
Comments would be most helpful if
received by September 5, 2008.
Comments received after that date will
be considered if it is practical to do so,
but the NRC is able to ensure
consideration only for comments
received on or before this date.
Although a time limit is given,
comments and suggestions in
connection with items for inclusion in
guides currently being developed or
improvements in all published guides
are encouraged at any time.
Electronic copies of DG–1198 are
available through the NRC’s public Web
site under Draft Regulatory Guides in
the ‘‘Regulatory Guides’’ collection of
the NRC’s Electronic Reading Room at
https://www.nrc.gov/reading-rm/doccollections/. Electronic copies are also
available in ADAMS (https://
www.nrc.gov/reading-rm/adams.html),
under Accession No. ML081080301.
In addition, regulatory guides are
available for inspection at the NRC’s
Public Document Room (PDR), which is
located at 11555 Rockville Pike,
Rockville, Maryland. The PDR’s mailing
address is USNRC PDR, Washington, DC
20555–0001. The PDR can also be
reached by telephone at (301) 415–4737
or (800) 397–4205, by fax at (301) 415–
3548, and by e-mail to PDR@nrc.gov.
Regulatory guides are not
copyrighted, and Commission approval
is not required to reproduce them.
Dated at Rockville, Maryland, this 2nd day
of July, 2008.
For the Nuclear Regulatory Commission.
Stephen C. O’Connor,
Acting Chief, Regulatory Guide Development
Branch, Division of Engineering, Office of
Nuclear Regulatory Research.
[FR Doc. E8–15674 Filed 7–9–08; 8:45 am]
BILLING CODE 7590–01–P
PO 00000
Frm 00087
Fmt 4703
Sfmt 4703
NUCLEAR REGULATORY
COMMISSION
[Docket No. 030–19324]
Notice of Availability of Environmental
Assessment and Finding of No
Significant Impact for License
Amendment to Byproduct Materials
License No. 25–19852–01 for
Unrestricted Release of Building 11 of
the GlaxoSmithKline BiologicalsHamilton Facility in Hamilton, MT
Nuclear Regulatory
Commission.
ACTION: Issuance of Environmental
Assessment and Finding of No
Significant Impact for License
Amendment.
AGENCY:
FOR FURTHER INFORMATION CONTACT:
Rachel S. Browder, Health Physicist,
Nuclear Materials Safety Branch B,
Division of Nuclear Materials Safety,
Region IV, U.S. Nuclear Regulatory
Commission, 612 Lamar Drive, Suite
400, Arlington, Texas 76011; telephone:
(817) 276–6552; fax number: (817) 860–
8188; or by e-mail:
rachel.browder@nrc.gov.
SUPPLEMENTARY INFORMATION:
I. Introduction
The U.S. Nuclear Regulatory
Commission (NRC) is considering the
issuance of a license amendment to
Byproduct Materials License No. 25–
19852–01. The license is held by
GlaxoSmithKline Biologicals-Hamilton
(the Licensee), for its Hamilton facility
(the Facility), located at 553 Old
Corvallis Road in Hamilton, Montana.
Issuance of the amendment would
authorize release of Building 11 of the
Facility for unrestricted use. The
Licensee requested this action in a letter
dated December 21, 2007. The NRC has
prepared an Environmental Assessment
(EA) in support of this proposed action
in accordance with the requirements of
title 10, Code of Federal Regulations
(CFR), part 51 (10 CFR part 51). Based
on the EA, the NRC has concluded that
a Finding of No Significant Impact
(FONSI) is appropriate with respect to
the proposed action. The amendment
will be issued to the Licensee following
the publication of this FONSI and EA in
the Federal Register.
II. Environmental Assessment
Identification of Proposed Action
The proposed action would approve
the Licensee’s December 21, 2007
license amendment request, resulting in
the release of the stand-alone Building
11 at the Facility for unrestricted use.
NRC License No. 25–19852–01 was
E:\FR\FM\10JYN1.SGM
10JYN1
Federal Register / Vol. 73, No. 133 / Thursday, July 10, 2008 / Notices
issued on June 24, 1988, pursuant to 10
CFR part 30, and has been amended
periodically since that time. This
license authorizes the Licensee to
possess and use small quantities of
byproduct material, in both sealed and
unsealed form, for laboratory research in
immunological and biochemical studies.
Additionally, the license authorizes the
Licensee to possess and use a selfshielded irradiator device and to
possess and use sealed sources for the
purposes of performing instrument
calibration.
The Facility is situated on 35 acres
(14 hectares) and consists of a main
building comprised of office space and
laboratories as well as several smaller
buildings used for various purposes.
The Facility is located in a mixed
residential/commercial area. The
Licensee’s December 21, 2007, license
amendment request specifically
addressed the release of Building 11 at
the Facility for unrestricted use.
Building 11 was used as a storage
building to store equipment, wood
shavings (animal bedding for a
vivarium), biomedical waste materials
and low level radioactive waste. The
building was originally designed as an
overhead shelter. In 2004 walls were
added to divide a potion of the structure
into four rooms. The building was
constructed with a concrete slab floor,
wood framing and walls, and a sheet
metal roof. There are no floor drains or
other fixtures such as sinks with
plumbing inside Building 11. The center
east room within Building 11 is the only
area licensed for storage and decay of
low level radioactive materials. The
floor dimensions of the center east room
are approximately 8 feet (2.4 meters) by
20 feet (6.1 meters).
The Licensee removed the low-level
radioactive materials from Building 11
and initiated a final status survey for the
stand-alone building. The Licensee was
not required to submit a
decommissioning plan to the NRC. The
Licensee conducted surveys of the
center east room of Building 11 and
provided information to the NRC to
demonstrate that it meets the criteria in
subpart E of 10 CFR part 20 for
unrestricted release.
jlentini on PROD1PC65 with NOTICES
Need for the Proposed Action
The Licensee has ceased conducting
licensed activities in the stand-alone
Building 11 of the Facility and seeks the
unrestricted use of Building 11.
Environmental Impacts of the Proposed
Action
The low level wastes generated as a
result of the licensed activities at the
Facility consisted of the following
VerDate Aug<31>2005
16:58 Jul 09, 2008
Jkt 214001
radionuclides with half-lives greater
than 120 days: hydrogen-3 (tritium),
carbon-14, and calcium-45. The
radioactive materials were in the form of
dry-solids, sharps, scintillation vials,
and bulk liquid in polypropylene
carboys. The licensee stored the low
level radioactive wastes in plastic lined
UN 55 gallon steel drums and stored the
drums in the center east room of
Building 11. The drums were never
opened while stored in Building 11.
Prior to performing the final status
survey, the Licensee removed the low
level radioactive drums from Building
11.
The Licensee conducted a final status
survey during November and December
2007. This survey covered the center
east room of Building 11. The final
status survey report was attached to the
Licensee’s amendment request dated
December 21, 2007. NRC regulation 10
CFR 20.1402, Radiological Criteria for
Unrestricted Use, states in part that a
site will be considered acceptable for
unrestricted use if the residual
radioactivity that is distinguishable
from background radiation results in a
total effective dose equivalent not to
exceed 25 millirems per year (0.25
milliSeiverts per year) to an average
member of the critical group (the group
of individuals reasonably expected to
receive the greatest exposure to residual
radioactivity for any applicable set of
circumstances). The Licensee elected to
demonstrate compliance with the
radiological criteria for unrestricted use
as specified in 10 CFR 20.1402 by
comparing the final status survey results
to background radiation levels for the
area. Since the Licensee’s survey results
did not identify any radioactive
contamination in excess of background
radiation levels for the area, then the
results adequately met the criteria for
unrestricted use. Accordingly, the
Licensee’s final status survey results
were acceptable.
Based on its review, the staff has
determined that the affected
environment and any environmental
impacts associated with the proposed
action are bounded by the impacts
evaluated by the ‘‘Generic
Environmental Impact Statement in
Support of Rulemaking on Radiological
Criteria for License Termination of NRCLicensed Nuclear Facilities’’ (NUREG–
1496) Volumes 1–3 (ML042310492,
ML042320379, and ML042330385).
Further, no incidents were recorded
involving spills or releases of
radioactive material in Building 11 of
the Facility. Accordingly, there were no
significant environmental impacts from
the use of radioactive material at the
Facility.
PO 00000
Frm 00088
Fmt 4703
Sfmt 4703
39733
The NRC staff finds that the proposed
release of the portion of the Facility
described above for unrestricted use is
in compliance with 10 CFR 20.1402.
The NRC has found no other activities
in the area that could result in
cumulative environmental impacts.
Based on its review, the staff considered
the impact of the residual radioactivity
at Building 11 of the Facility and
concluded that the proposed action will
not have a significant effect on the
quality of the human environment.
Environmental Impacts of the
Alternatives to the Proposed Action
Due to the largely administrative
nature of the proposed action, its
environmental impacts are small.
Therefore, the only alternative the staff
considered is the no-action alternative,
under which the staff would simply
deny the amendment request. This noaction alternative is not feasible because
it conflicts with 10 CFR 30.36(d),
requiring that decommissioning of
byproduct material facilities be
completed and approved by the NRC
after licensed activities cease.
Additionally, this denial of the
application would result in no change
in current environmental impacts. The
environmental impacts of the proposed
action and the no-action alternative are
similar, and the no-action alternative is
accordingly not further considered.
Conclusion
The NRC staff has concluded that the
proposed action is consistent with the
NRC’s unrestricted release criteria
specified in 10 CFR 20.1402. Because
the proposed action will not
significantly impact the quality of the
human environment, the NRC staff
concludes that the proposed action is
the preferred alternative.
Agencies and Persons Consulted
NRC provided a draft of this EA to the
State of Montana Department of Public
Health and Human Services for review
on April 25, 2008. The State of Montana
Department of Public Health and
Human Services did not have any
comments to the draft EA.
The NRC staff has determined that the
proposed action is of a procedural
nature and will not affect listed species
or critical habitat. Therefore, no
consultation is required under Section 7
of the Endangered Species Act. The
NRC staff has also determined that the
proposed action is not the type of
activity that has the potential to cause
effects on historic properties. Therefore,
no consultation is required under
Section 106 of the National Historic
Preservation Act.
E:\FR\FM\10JYN1.SGM
10JYN1
39734
Federal Register / Vol. 73, No. 133 / Thursday, July 10, 2008 / Notices
III. Finding of No Significant Impact
The NRC staff has prepared this EA in
support of the proposed action. On the
basis of this EA, the NRC finds that
there are no significant environmental
impacts from the proposed action, and
that preparation of an environmental
impact statement is not warranted.
Accordingly, the NRC has determined
that a Finding of No Significant Impact
is appropriate.
jlentini on PROD1PC65 with NOTICES
IV. Further Information
Documents related to this action,
including the application for license
amendment and supporting
documentation, are available
electronically at the NRC’s Electronic
Reading Room at https://www.nrc.gov/
reading-rm/adams.html. From this site,
you can access the NRC’s Agencywide
Document Access and Management
System (ADAMS), which provides text
and image files of NRC’s public
documents. The documents related to
this action are listed below, along with
their ADAMS accession numbers, if
applicable.
1. Federal Register Notice, Volume
65, No. 114, page 37186, dated Tuesday,
June 13, 2000, ‘‘Use of Screening Values
to Demonstrate Compliance With The
Federal Rule on Radiological Criteria for
License Termination;’’
2. NRC, ‘‘Generic Environmental
Impact Statement in Support of
Rulemaking on Radiological Criteria for
License Termination of NRC-Licensed
Nuclear Facilities,’’ NUREG–1496, July
1997 (ML042310492, ML042320379,
and ML042330385);
3. NRC, ‘‘Consolidated NMSS
Decommissioning Guidance,’’ NUREG–
1757, Volume 1, Revision 1, September
2003 (ML053260027);
4. Title 10 Code of Federal
Regulations, Part 20, Subpart E,
‘‘Radiological Criteria for License
Termination;’’
5. Title 10, Code of Federal
Regulations, Part 51, ‘‘Environmental
Protection Regulations for Domestic
Licensing and Related Regulatory
Functions;’’
6. Poletti, Brian, GlaxoSmithKline
Biologicals—Hamilton, License
Amendment Request dated December
21, 2007 (ML080380101).
If you do not have access to ADAMS,
or if there are problems in accessing the
documents located in ADAMS, contact
the NRC Public Document Room (PDR)
Reference staff at 1–800–397–4209, 301–
415–4737, or by e-mail to
pdr.rosource@nrc.gov. These documents
may also be viewed electronically on
the public computers located at the
NRC’s PDR, O 1 F21, One White Flint
VerDate Aug<31>2005
16:58 Jul 09, 2008
Jkt 214001
North, 11555 Rockville Pike, Rockville,
MD 20852. The PDR reproduction
contractor will copy documents for a
fee.
Dated at Arlington, Texas this 27th day of
June 2008.
For the Nuclear Regulatory Commission.
Jack E. Whitten,
Chief, Nuclear Materials Safety Branch B,
Division of Nuclear Materials Safety, Region
IV.
[FR Doc. E8–15675 Filed 7–9–08; 8:45 am]
BILLING CODE 7590–01–P
NUCLEAR REGULATORY
COMMISSION
[Docket No. 030–33658]
Notice of Availability of Environmental
Assessment and Finding of No
Significant Impact for License
Amendment Request to Byproduct
Materials License 01–25316–01 for the
Department of Defense, Defense
Intelligence Agency, Redstone
Arsenal, AL
Nuclear Regulatory
Commission.
ACTION: Issuance of Environmental
Assessment and Finding of No
Significant Impact for License
Amendment.
AGENCY:
FOR FURTHER INFORMATION CONTACT:
Thomas Thompson, Senior Health
Physicist, Commercial and R&D Branch,
Division of Nuclear Materials Safety,
Region I, 475 Allendale Road, King of
Prussia, PA 19406. Telephone: (610)
337–5303; fax number: (610) 337–5269;
e-mail: TKT@nrc.gov.
SUPPLEMENTARY INFORMATION:
I. Introduction
The U.S. Nuclear Regulatory
Commission (NRC) is considering the
issuance of a license renewal to
Byproduct Materials License No. 01–
25316–01. This license is held by the
Department of Defense, Defense
Intelligence Agency (the Licensee), for
activities conducted at the Redstone
Arsenal facility, located in Redstone
Arsenal, Alabama. As part of its license
renewal, the Licensee has requested an
exemption from the requirement in 10
CFR 30.32(g) to list sealed sources by
their manufacturer and model number
as registered under the provisions of 10
CFR 32.210. The Licensee requested this
exemption in a letter received on
November 1, 2005. The NRC has
prepared an Environmental Assessment
(EA) in support of this proposed action
in accordance with the requirements of
Title 10, Code of Federal Regulations
PO 00000
Frm 00089
Fmt 4703
Sfmt 4703
(CFR), Part 51 (10 CFR Part 51). Based
on the EA, the NRC has concluded that
a Finding of No Significant Impact
(FONSI) is appropriate with respect to
the proposed action. The license
renewal, including the approval of the
exemption request, will be issued to the
Licensee following the publication of
this FONSI and EA in the Federal
Register.
II. Environmental Assessment
Identification of Proposed Action
The proposed action would renew
License No. 01–25316–01, including
approval of the Licensee’s request for
exemption received on November 1,
2005. License No. 01–25316–01 was
issued on January 26, 1995, pursuant to
10 CFR Parts 30 and 70, and has been
amended periodically since that time.
This license authorized the Licensee to
receive, store, use and/or transfer
specified radioactive materials incident
to research and development as defined
in 10 CFR 30.4.
On December 29, 2004, the Licensee
submitted its renewal application for
License No. 01–25316–01. In a letter
received on November 1, 2005,
submitted in response to an inquiry
from the NRC, the Licensee requested an
exemption from the requirement in 10
CFR 30.32(g) to list sealed sources by
their manufacturer and model number
as registered under the provisions of 10
CFR 32.210. In requesting this
exemption, the Licensee states that the
sole purpose of possessing the sealed
sources on this license ‘‘is to be able to
remove and store for disposal devices of
foreign manufacture which may be
contained on, or in, foreign military
vehicles or conveyances.’’ Furthermore,
the Licensee states that it will not know
in advance what sources or devices may
be received at its facility and that, in the
interest of national security and
Department of Defense policy, the
sources or origination of foreign
equipment cannot be revealed. The
Licensee states that it immediately
surveys all such foreign vehicles for
radioactive material and places them in
storage for future disposal if radioactive
contamination is found.
Need for the Proposed Action
The Licensee receives and takes
possession of sealed sources and
devices which have not been registered
with the NRC under 10 CFR 32.210 or
with an Agreement State. As these
sources and devices are of foreign
manufacture, the Licensee would not be
able to continue this activity without
this exemption.
E:\FR\FM\10JYN1.SGM
10JYN1
]]>Agencies
[Federal Register Volume 73, Number 133 (Thursday, July 10, 2008)]
[Notices]
[Pages 39732-39734]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-15675]
-----------------------------------------------------------------------
NUCLEAR REGULATORY COMMISSION
[Docket No. 030-19324]
Notice of Availability of Environmental Assessment and Finding of
No Significant Impact for License Amendment to Byproduct Materials
License No. 25-19852-01 for Unrestricted Release of Building 11 of the
GlaxoSmithKline Biologicals-Hamilton Facility in Hamilton, MT
AGENCY: Nuclear Regulatory Commission.
ACTION: Issuance of Environmental Assessment and Finding of No
Significant Impact for License Amendment.
-----------------------------------------------------------------------
FOR FURTHER INFORMATION CONTACT: Rachel S. Browder, Health Physicist,
Nuclear Materials Safety Branch B, Division of Nuclear Materials
Safety, Region IV, U.S. Nuclear Regulatory Commission, 612 Lamar Drive,
Suite 400, Arlington, Texas 76011; telephone: (817) 276-6552; fax
number: (817) 860-8188; or by e-mail: rachel.browder@nrc.gov.
SUPPLEMENTARY INFORMATION:
I. Introduction
The U.S. Nuclear Regulatory Commission (NRC) is considering the
issuance of a license amendment to Byproduct Materials License No. 25-
19852-01. The license is held by GlaxoSmithKline Biologicals-Hamilton
(the Licensee), for its Hamilton facility (the Facility), located at
553 Old Corvallis Road in Hamilton, Montana. Issuance of the amendment
would authorize release of Building 11 of the Facility for unrestricted
use. The Licensee requested this action in a letter dated December 21,
2007. The NRC has prepared an Environmental Assessment (EA) in support
of this proposed action in accordance with the requirements of title
10, Code of Federal Regulations (CFR), part 51 (10 CFR part 51). Based
on the EA, the NRC has concluded that a Finding of No Significant
Impact (FONSI) is appropriate with respect to the proposed action. The
amendment will be issued to the Licensee following the publication of
this FONSI and EA in the Federal Register.
II. Environmental Assessment
Identification of Proposed Action
The proposed action would approve the Licensee's December 21, 2007
license amendment request, resulting in the release of the stand-alone
Building 11 at the Facility for unrestricted use. NRC License No. 25-
19852-01 was
[[Page 39733]]
issued on June 24, 1988, pursuant to 10 CFR part 30, and has been
amended periodically since that time. This license authorizes the
Licensee to possess and use small quantities of byproduct material, in
both sealed and unsealed form, for laboratory research in immunological
and biochemical studies. Additionally, the license authorizes the
Licensee to possess and use a self-shielded irradiator device and to
possess and use sealed sources for the purposes of performing
instrument calibration.
The Facility is situated on 35 acres (14 hectares) and consists of
a main building comprised of office space and laboratories as well as
several smaller buildings used for various purposes. The Facility is
located in a mixed residential/commercial area. The Licensee's December
21, 2007, license amendment request specifically addressed the release
of Building 11 at the Facility for unrestricted use. Building 11 was
used as a storage building to store equipment, wood shavings (animal
bedding for a vivarium), biomedical waste materials and low level
radioactive waste. The building was originally designed as an overhead
shelter. In 2004 walls were added to divide a potion of the structure
into four rooms. The building was constructed with a concrete slab
floor, wood framing and walls, and a sheet metal roof. There are no
floor drains or other fixtures such as sinks with plumbing inside
Building 11. The center east room within Building 11 is the only area
licensed for storage and decay of low level radioactive materials. The
floor dimensions of the center east room are approximately 8 feet (2.4
meters) by 20 feet (6.1 meters).
The Licensee removed the low-level radioactive materials from
Building 11 and initiated a final status survey for the stand-alone
building. The Licensee was not required to submit a decommissioning
plan to the NRC. The Licensee conducted surveys of the center east room
of Building 11 and provided information to the NRC to demonstrate that
it meets the criteria in subpart E of 10 CFR part 20 for unrestricted
release.
Need for the Proposed Action
The Licensee has ceased conducting licensed activities in the
stand-alone Building 11 of the Facility and seeks the unrestricted use
of Building 11.
Environmental Impacts of the Proposed Action
The low level wastes generated as a result of the licensed
activities at the Facility consisted of the following radionuclides
with half-lives greater than 120 days: hydrogen-3 (tritium), carbon-14,
and calcium-45. The radioactive materials were in the form of dry-
solids, sharps, scintillation vials, and bulk liquid in polypropylene
carboys. The licensee stored the low level radioactive wastes in
plastic lined UN 55 gallon steel drums and stored the drums in the
center east room of Building 11. The drums were never opened while
stored in Building 11. Prior to performing the final status survey, the
Licensee removed the low level radioactive drums from Building 11.
The Licensee conducted a final status survey during November and
December 2007. This survey covered the center east room of Building 11.
The final status survey report was attached to the Licensee's amendment
request dated December 21, 2007. NRC regulation 10 CFR 20.1402,
Radiological Criteria for Unrestricted Use, states in part that a site
will be considered acceptable for unrestricted use if the residual
radioactivity that is distinguishable from background radiation results
in a total effective dose equivalent not to exceed 25 millirems per
year (0.25 milliSeiverts per year) to an average member of the critical
group (the group of individuals reasonably expected to receive the
greatest exposure to residual radioactivity for any applicable set of
circumstances). The Licensee elected to demonstrate compliance with the
radiological criteria for unrestricted use as specified in 10 CFR
20.1402 by comparing the final status survey results to background
radiation levels for the area. Since the Licensee's survey results did
not identify any radioactive contamination in excess of background
radiation levels for the area, then the results adequately met the
criteria for unrestricted use. Accordingly, the Licensee's final status
survey results were acceptable.
Based on its review, the staff has determined that the affected
environment and any environmental impacts associated with the proposed
action are bounded by the impacts evaluated by the ``Generic
Environmental Impact Statement in Support of Rulemaking on Radiological
Criteria for License Termination of NRC-Licensed Nuclear Facilities''
(NUREG-1496) Volumes 1-3 (ML042310492, ML042320379, and ML042330385).
Further, no incidents were recorded involving spills or releases of
radioactive material in Building 11 of the Facility. Accordingly, there
were no significant environmental impacts from the use of radioactive
material at the Facility.
The NRC staff finds that the proposed release of the portion of the
Facility described above for unrestricted use is in compliance with 10
CFR 20.1402. The NRC has found no other activities in the area that
could result in cumulative environmental impacts. Based on its review,
the staff considered the impact of the residual radioactivity at
Building 11 of the Facility and concluded that the proposed action will
not have a significant effect on the quality of the human environment.
Environmental Impacts of the Alternatives to the Proposed Action
Due to the largely administrative nature of the proposed action,
its environmental impacts are small. Therefore, the only alternative
the staff considered is the no-action alternative, under which the
staff would simply deny the amendment request. This no-action
alternative is not feasible because it conflicts with 10 CFR 30.36(d),
requiring that decommissioning of byproduct material facilities be
completed and approved by the NRC after licensed activities cease.
Additionally, this denial of the application would result in no change
in current environmental impacts. The environmental impacts of the
proposed action and the no-action alternative are similar, and the no-
action alternative is accordingly not further considered.
Conclusion
The NRC staff has concluded that the proposed action is consistent
with the NRC's unrestricted release criteria specified in 10 CFR
20.1402. Because the proposed action will not significantly impact the
quality of the human environment, the NRC staff concludes that the
proposed action is the preferred alternative.
Agencies and Persons Consulted
NRC provided a draft of this EA to the State of Montana Department
of Public Health and Human Services for review on April 25, 2008. The
State of Montana Department of Public Health and Human Services did not
have any comments to the draft EA.
The NRC staff has determined that the proposed action is of a
procedural nature and will not affect listed species or critical
habitat. Therefore, no consultation is required under Section 7 of the
Endangered Species Act. The NRC staff has also determined that the
proposed action is not the type of activity that has the potential to
cause effects on historic properties. Therefore, no consultation is
required under Section 106 of the National Historic Preservation Act.
[[Page 39734]]
III. Finding of No Significant Impact
The NRC staff has prepared this EA in support of the proposed
action. On the basis of this EA, the NRC finds that there are no
significant environmental impacts from the proposed action, and that
preparation of an environmental impact statement is not warranted.
Accordingly, the NRC has determined that a Finding of No Significant
Impact is appropriate.
IV. Further Information
Documents related to this action, including the application for
license amendment and supporting documentation, are available
electronically at the NRC's Electronic Reading Room at https://
www.nrc.gov/reading-rm/adams.html. From this site, you can access the
NRC's Agencywide Document Access and Management System (ADAMS), which
provides text and image files of NRC's public documents. The documents
related to this action are listed below, along with their ADAMS
accession numbers, if applicable.
1. Federal Register Notice, Volume 65, No. 114, page 37186, dated
Tuesday, June 13, 2000, ``Use of Screening Values to Demonstrate
Compliance With The Federal Rule on Radiological Criteria for License
Termination;''
2. NRC, ``Generic Environmental Impact Statement in Support of
Rulemaking on Radiological Criteria for License Termination of NRC-
Licensed Nuclear Facilities,'' NUREG-1496, July 1997 (ML042310492,
ML042320379, and ML042330385);
3. NRC, ``Consolidated NMSS Decommissioning Guidance,'' NUREG-1757,
Volume 1, Revision 1, September 2003 (ML053260027);
4. Title 10 Code of Federal Regulations, Part 20, Subpart E,
``Radiological Criteria for License Termination;''
5. Title 10, Code of Federal Regulations, Part 51, ``Environmental
Protection Regulations for Domestic Licensing and Related Regulatory
Functions;''
6. Poletti, Brian, GlaxoSmithKline Biologicals--Hamilton, License
Amendment Request dated December 21, 2007 (ML080380101).
If you do not have access to ADAMS, or if there are problems in
accessing the documents located in ADAMS, contact the NRC Public
Document Room (PDR) Reference staff at 1-800-397-4209, 301-415-4737, or
by e-mail to pdr.rosource@nrc.gov. These documents may also be viewed
electronically on the public computers located at the NRC's PDR, O 1
F21, One White Flint North, 11555 Rockville Pike, Rockville, MD 20852.
The PDR reproduction contractor will copy documents for a fee.
Dated at Arlington, Texas this 27th day of June 2008.
For the Nuclear Regulatory Commission.
Jack E. Whitten,
Chief, Nuclear Materials Safety Branch B, Division of Nuclear Materials
Safety, Region IV.
[FR Doc. E8-15675 Filed 7-9-08; 8:45 am]
BILLING CODE 7590-01-P
